- American Board of Internal Medicine - Cardiovascular Disease
- American Board of Internal Medicine - Internal Medicine
- American Board of Internal Medicine - Interventional Cardiology
- Wayne State University, MI, 1977
Residencies & Internships
- Wayne State University, Internal Medicine, MI, 1980
- University of Wisconsin, Internal Medicine, WI, 1978
- University of Michigan, Cardiovascular Disease, MI, 1982
Titles: Medical Director, Center for Structural Heart Disease
Dr. O’Neill, is an internationally recognized leader in Interventional Cardiology and Structural Heart Disease, as well as a pioneer in research and new techniques to diagnose and treat heart disease.
Dr. O’Neill is one of the few Master Fellows out of 4,500 world-wide members of the Society for Cardiovascular Angiography and Interventions (MSCAI), the professional medical society for invasive and interventional cardiologists. He pioneered the use of angioplasty for treatment of heart attacks, which is now the mainstay therapy throughout the world. He has been working on new catheter-based treatments of structural heart disease, and performed the first transcaval aortic valve replacement (TAVR) through a catheter in the U.S. in 2005. Currently he is organizing new protocols to treat a deadly side-effect of massive heart attacks, known as the National Cardiogenic Shock Initiative (NCSI). This initiative has proven to increase patient survival rates from 50% to 76%.
A leader in academic and teaching hospitals for nearly 30 years, and to date, an author of more than 300 hundred peer-reviewed articles and abstracts published in medical literature, Dr. O’Neill has written multiple book chapters, and edited one of the first textbooks in the field of interventional cardiologists. He was a founding member of the American Board of Internal Medicine interventional cardiology board, which certifies all interventional cardiologists.
Awards & Honors:
Dr. O’Neill has received multiple awards and recognitions in his career. They include: America's Top Doctors; Transcatheter Cardiovascular Therapeutics Lifetime Achievement Award, and the Seymour Gordon Award for Distinguished Achievement, Michigan Chapter, American Heart Association. He was also the founding chair, Innovation in Intervention Summit, of the American College of Cardiology.
An interventional cardiologist explains what structural heart disease is and the treatments available, such as TAVR, a minimally invasive heart valve replacement procedure.
TAVR, or transcatheter aortic valve replacement, used to be limited to patients too high risk for open-heart surgery but a new FDA decision allows the less invasive procedure to be used in even low-risk patients who need a new aortic heart valve.
- Henry Ford Allegiance Health
- Henry Ford Hospital
- Henry Ford Macomb Hospital - Clinton Township